Stocktoria
ACCURAY INC ARAY
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-02-08
ACCURAY INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 32.1% | 32.0% | 34.4% | 37.2% | 40.3% |
| Operating margin | 1.7% | 0.1% | 0.5% | 1.9% | 5.6% |
| Net margin | -0.3% | -3.5% | -2.1% | -1.2% | -1.6% |
| FCF margin | -0.3% | -3.5% | 0.7% | -1.7% | 9.1% |
| Return on assets | -0.3% | -3.3% | -1.9% | -1.1% | -1.3% |
| Return on equity | -2.0% | -34.5% | -17.3% | -10.1% | -9.2% |
| Debt / equity | 1.68× | 3.82× | 3.30× | 3.39× | 2.52× |
| Current ratio | 1.65 | 1.66 | 1.70 | 1.68 | 1.83 |
| Revenue growth | 2.7% | -0.2% | 4.1% | 8.5% | 3.5% |
Source: SEC EDGAR filings · CIK 0001138723 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.